Protalix Biotherapeutics, Inc. (PLX)

1.97 -0.01 (-0.51%) USD  |  NYAM  |  Jun 10, 15:05
More

Protalix Biotherapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Altimmune, Inc. Upgrade
Humacyte, Inc. Upgrade
Amgen, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. Upgrade